FarmPharma has applied to participate in the EUREKA Eurostar program
FarmPharma AB (publ) (“FarmPharma” or “Company”), in cooperation with its partners from the Karolinska institute in the framework of an international consortium, has applied for a EUREKA Eurostars grant for call 15. Besides FarmPharma, which is a coordinator of the consortium and Karolinska Institute, two organisations from France and Slovenia participate in the project which is devoted for the development of the InterferOX product. The final decision on grant is expected in June 2021. The budget of the grant for 2 years is about 1,6 M€.
“We are very excited with the possibility of joint forces to develop our product, especially now when needs for antiviral products are extremely unmet, – comments Irina Zaitseva, CEO of FarmPharma”.
More about FarmPharma:
FarmPharma AB operates in the development and distribution of veterinary products, and their first product is for prevention and treatment of bacterial and viral infections in cattle without the use of antibiotics. For more info please contact Irina Zaitseva, the company’s CEO.
Video presentation:
Follow us on:
FarmPharma has applied to participate in the EUREKA Eurostar program
FarmPharma AB (publ) (“FarmPharma” or “Company”), in cooperation with its partners from the Karolinska institute in the framework of an international consortium, has applied for a EUREKA Eurostars grant for call 15. Besides FarmPharma, which is a coordinator of the consortium and Karolinska Institute, two organisations from France and Slovenia participate in the project which is devoted for the development of the InterferOX product. The final decision on grant is expected in June 2021. The budget of the grant for 2 years is about 1,6 M€.
“We are very excited with the possibility of joint forces to develop our product, especially now when needs for antiviral products are extremely unmet, – comments Irina Zaitseva, CEO of FarmPharma”.
More about FarmPharma:
FarmPharma AB operates in the development and distribution of veterinary products, and their first product is for prevention and treatment of bacterial and viral infections in cattle without the use of antibiotics. For more info please contact Irina Zaitseva, the company’s CEO.
Video presentation:
Follow us on: